Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 31250167.
- Also identified by DOI 10.1007/s00330-019-06302-9.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To study a muscle-to-muscle standardised uptake value (SUV) ratio with FDG-PET/CT (FDG-PET) as a marker for the detection of disease activity in dermatomyositis (DM). Patients with DM (n = 24) who met the European Neuro-Muscular Centre diagnostic criteria were retrospectively identified over a 3-year period through a national survey. Muscle biopsy was performed in all patients. Maximum SUV was measured in proximal muscles (SUV<sub>PROX</sub>) that had the highest radiotracer uptake on visual grading as well as in the musculus longissimus thoracis (SUV<sub>MLT</sub>), whereas mean SUV was measured for the liver (SUV<sub>LIV</sub>). Muscle-to-liver SUV ratios for either muscle group were compared and a SUV<sub>PROX</sub>/SUV<sub>MLT</sub> ratio was calculated. SUV<sub>PROX</sub>/SUV<sub>MLT</sub> of DM patients were compared with age- and sex-matched control subjects (n = 24) with melanoma who had received FDG-PET scans. DM patients presented with proximal and symmetrical muscle uptake. Differences in SUV<sub>PROX</sub>/SUV<sub>LIV</sub> and SUV<sub>MLT</sub>/SUV<sub>LIV</sub> ratios in DM subjects were significant (p < 0.001). SUV<sub>PROX</sub>/SUV<sub>MLT</sub> ratios in DM and their controls also differed significantly (p = 0.0012). The SUV<sub>PROX</sub>/SUV<sub>MLT</sub> ratio threshold between DM subjects and controls was 1.73 with a sensitivity of 50% (CI95%, 29.1 to 70.9%) and specificity at 83.3% (CI95%, 62.6 to 95.3%). When amyopathic DM patients were removed from the analysis, specificity was increased to 95% (CI95%, 75.1 to 99.9%) with a likelihood ratio of 10 and an AUC of 83.4% (CI95%, 71.4 to 95.4%). A muscle-to-muscle SUV<sub>PROX</sub>/SUV<sub>MLT</sub> ratio with a cut-off value of 1.73 in FDG-PET imaging might serve as a non-invasive marker to determine disease activity in dermatomyositis. • [18F]-FDG PET-scanner standardised uptake value (SUV) could reflect disease activity in dermatomyositis (DM). • A ratio of SUV in proximal muscles (SUV<sub>PROX</sub>) to SUV in musculus longissimus thoracis (SUV<sub>MLT</sub>) could be used to determine active DM. • Active disease is suspected for SUV <sub>PROX</sub> /SUV <sub>MLT</sub> ratios greater than 1.73.
Medical subject headings
- Dermatomyositis
- Fluorodeoxyglucose F18
- Muscle, Skeletal
- Positron Emission Tomography Computed Tomography
- Radiopharmaceuticals